About the Company
We do not have any company description for Kiromic Biopharma, Inc. at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Kiromic Biopharma, Inc.
Kiromic BioPharma Activates the University of Arizona Cancer ... - Nasdaq
Kiromic BioPharma, Inc. announces that the University of Arizona Cancer Center has been activated as the fifth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltacel™, Kiromic ...
Kiromic BioPharma Reports Favorable Ongoing Clinical Results From ...
Kiromic BioPharma, Inc. reports favorable ongoing efficacy results from follow-up visits for Patient 4 and Patient 6 in its Deltacel-01 Phase 1 clinical trial. Both of these patients are being ...
Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the ...
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) 2.0 target discovery engine to develop and ...
Kiromic BioPharma Reports Six-Month Results from First Patient Enrolled ...
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) 2.0 target discovery engine to develop and ...
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months ...
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company developing a multi-indication allogeneic cell therapy platform that exploits the natural potency of Gamma ...
Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following ...
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) 2.0 target discovery engine to develop and ...
Kiromic Biopharma settles SEC charges over misleading investors ...
SEC settles charges with Kiromic Biopharma for misleading investors, issues penalties for former execs Unlock URL Order Reprints Gift this Article ...
Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2 ...
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) 2.0 target discovery engine to develop and ...
Kiromic Biopharma Inc. Company & People | KRBP | Barron's
The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX. Kiromic Biopharma Inc. 7707 Fannin Street Houston, Texas 1 832 968-4888 ...
Kiromic BioPharma Inc Ordinary Shares KRBPQ - Morningstar
News Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival Business Wire Feb 18, 2025 5:00am ...
Similar Companies
Loading the latest forecasts...